Developer docs
API playgroundTry for free, no card

Search company profiles

The EHE Foundation

Full company profile

uuid003hx68

Namestring
The EHE Foundation
Legal namestring
EHE Foundation
Websiteurl
fightehe.org
Company typeenum
Private
Founded yearint
2015
Descriptiontext

The EHE Foundation is a 501(c)(3) nonprofit organization founded in 2015 and headquartered in Hobart, Wisconsin (Green Bay area), dedicated to finding treatments and a cure for epithelioid hemangioendothelioma, an ultra-rare vascular sarcoma affecting fewer than 1 in 1 million people. It serves a global community of EHE patients, caregivers, researchers, and clinicians across at least 19 countries and five continents, and operates with a lean distributed team of 1-10 staff under Executive Director Denise Robinson.

The foundation's core offerings combine patient services with proprietary research infrastructure. Its technology stack centers on the EHE Global Patient Registry, hosted on the National Organization for Rare Disorders' IAMRARE platform, which collects standardized natural history data, and the EHE Biobank (established 2020), which distributes tissue and biospecimens to qualified researchers. Structured clinical data is enabled through a partnership with xCures. Patient-facing services include virtual support groups, a provider directory, clinical trial listings, the EHE Library of approximately 200 EHE-specific publications, and the monthly EHE 360 Connect webinar series, all provided free of charge. The annual EHE 360 Global Conference convenes the international community; the 2026 edition drew 187 registrants from 19 countries.

The foundation's business model is donation-driven rather than revenue-driven, consistent with its 501(c)(3) status. Funding is generated through individual donations processed via the Zeffy platform, the annual EHE Fun Run & Walk (per-registrant fees of $45 US / $65 international), corporate sponsorships (including Aadi Bioscience and SpringWorks Therapeutics), EHE Awareness Month campaigns, and grants. The foundation channels donor funds into a Research Grants Program that has committed over $2 million cumulatively to academic collaborators including Memorial Sloan Kettering, Cleveland Clinic, Albany Medical College, MIT Koch Institute, and Istituto Nazionale dei Tumori, and into operational infrastructure that supports a co-funded Department of Defense rare-cancer drug-target discovery platform and SARC's SARC046 Phase 2 clinical trial.

Short descriptiontext

The EHE Foundation is a 501(c)(3) nonprofit founded in 2015 that operates the EHE Global Patient Registry, EHE Biobank, and annual EHE 360 Global Conference to advance research and support patients with epithelioid hemangioendothelioma, an ultra-rare sarcoma affecting fewer than 1 in 1 million people worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHobart, United States
HQ citystring
Hobart
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease research, patient advocacy services, sarcoma research funding, patient registry operations, tissue biobanking services
Industry1 code
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services8132
SIC code1 code
  • Services-Health Services8000
Product category
Rare Disease Patient Advocacy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Fundraising
TypeAffiliate Referral
Description

The EHE Foundation generates revenue primarily through individual donations, corporate sponsorships, and fundraising events including the annual EHE Fun Run & Walk and EHE Awareness Month campaigns. The foundation also receives grants from private donors and partner organizations.

fightehe.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The EHE Foundation is a nonprofit patient advocacy organization that delivers free patient services (newly-diagnosed guidance, provider directory, support groups, educational resources), maintains research infrastructure including the EHE Global Patient Registry and EHE Biobank, funds EHE research grants, and convenes the global EHE community through the annual EHE 360 Global Conference, EHE 360 Connect webinars, and the EHE Fun Run & Walk fundraising event. All offerings are provided at no cost to patients and caregivers, funded through donations, sponsorships, and fundraising.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over $2 million committed to EHE research globally
+2 more records
Product overview1 text field

The EHE Foundation offers a comprehensive suite of patient-focused services and research programs for Epithelioid Hemangioendothelioma (EHE), an ultra-rare vascular sarcoma. The core offerings include the EHE Global Patient Registry (hosted on NORD's IAMRARE platform) for patient-powered research data collection, the EHE Biobank for tissue and biospecimen donation, EHE Support Groups for peer support, EHE 360 Connect educational webinars, and the annual EHE 360 Global Conference. Additional resources include a Provider Directory, Clinical Trials Information, EHE Library of research publications, and the EHE Research Grants Program funding. Fundraising initiatives include the annual EHE Fun Run & Walk event.

Product and service10 records
1EHE Global Patient Registry
CategoryResearch Service
Description

An online global patient-powered natural history study that collects standardized information about EHE patients' experiences over time to advance research and support clinical trial recruitment. Hosted by NORD on the IAMRARE platform. Available for free to EHE patients worldwide.

2EHE Biobank
CategoryResearch Service
Description

An open, ongoing collection of tissue samples and biospecimens (blood, bodily fluids) donated by EHE patients. Samples are preserved and made available to qualified researchers to accelerate EHE research. Coordinated through the foundation's Biobank Coordinators.

3EHE Support Groups
CategoryPatient Service
Description

Free virtual meetings for adults affected by EHE, professionally led covering topics that help support patients newly affected by EHE as well as those who have lived with EHE longer. Available to EHE patients and caregivers globally.

4EHE 360 Connect
CategoryEducational Webinar
Description

Educational webinar program presenting information from clinicians and research communities on EHE topics. Recordings are archived and available for free viewing. Targets EHE patients, caregivers, researchers, and clinicians.

5EHE 360 Global Conference
CategoryAnnual Conference
Description

Annual virtual international forum bringing together patients, caregivers, researchers, clinicians, and industry partners for substantive scientific and clinical education on EHE. The 2026 conference drew 187 registrants from 19 countries spanning five continents.

6EHE Research Grants Program
CategoryResearch Funding
Description

Research grants program funding innovative basic, translational, and clinical proposals to advance scientific knowledge in EHE. The foundation has committed over $2,000,000 to advance EHE research globally through this program. Targets academic researchers and clinicians.

7EHE Fun Run & Walk
CategoryFundraising Event
Description

Annual virtual community-driven awareness and fundraising event supporting people affected by EHE. Participants register and can join from anywhere globally to raise funds and awareness for the EHE community.

8Provider Directory
CategoryPatient Resource
Description

A searchable and sortable directory of clinicians with experience treating EHE, designed to help patients find sarcoma specialists familiar with the ultra-rare disease. Available free to EHE patients.

9Clinical Trials Information
CategoryPatient Resource
Description

A continuously updated list of active clinical trials that include patients diagnosed with EHE, with details and contacts accessible via ClinicalTrials.gov. Provided free to EHE patients seeking treatment options.

10EHE Library
CategoryKnowledge Resource
Description

A collection of nearly 200 publications and articles about EHE research and treatments available online, including both open access and subscription-required articles. Targets researchers, clinicians, and informed patients.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NORD hosts the EHE Global Patient Registry on their IAMRARE platform, providing secure data collection infrastructure for natural history studies and clinical trial recruitment. NORD is a nonprofit leading the fight to improve lives of rare disease patients and families.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with xCures, a pioneer in healthcare data management, to gather medical information from EHE patients into structured, regulatory-grade clinical data. The platform collects and organizes medical data to study the natural history of EHE.

3CURE Drug Repurposing Collaboratory (CDRC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EHE Foundation partners with CDRC, an initiative of the Critical Path Institute, as a member of the Sarcoma Task Force and Rare Coordinating Committee. CDRC explores whether existing drugs can be repurposed for ultra-rare sarcomas like EHE.

fightehe.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with the MyPART network of NCI's Rare Tumors Initiative, focusing on accelerating translation of potential new therapies for rare tumors through a Natural History Study of Rare Solid Tumors.

5EHE Rare Cancer Charity (UK)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UK-based EHE organization co-funding the European EHE Research Collaboration with the Istituto Nazionale dei Tumori in Milan, Institute of Cancer Research (UK), and Royal Marsden Hospital.

fightehe.org
6EHE Rare Cancer Foundation Australia
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Australian EHE organization co-funding research grants including the Lamar Lab at Albany Medical College and the Antonescu lab at Memorial Sloan Kettering.

fightehe.org
7SARC
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SARC (Sarcoma Alliance for Clinical Research) is conducting the SARC046 Phase 2 clinical trial of nab-sirolimus in EHE patients, funded by the US Department of Defense.

fightehe.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with Dr. Ajaybabu Pobbati's lab investigating FDA-approved drug repurposing for EHE treatment and CDK9 inhibitors for aggressive metastatic EHE.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with Dr. John Lamar's lab investigating statins as potential EHE treatment and development of blood-based biomarkers for disease monitoring.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Dr. Jesse Boehm's lab, awarded a 3-year grant through the Department of Defense Rare Cancers Research Program, to create a platform for rare cancer drug target discovery using patient-donated tumor tissue.

11Fondazione IRCCS Istituto Nazionale dei Tumori (Milan, Italy)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Italian research institution collaborating on European EHE Research Collaboration evaluating cytokines and hormones as biomarkers for EHE, funded jointly with EHE Rare Cancer Charity UK.

fightehe.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Italian EHE patient organization contributing to the global EHE community and participating in EHE 360 Global Conference leadership.

13Rare Cancer EHE Deutschland e.V. (Germany)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

German EHE patient organization contributing to the global EHE community and represented at EHE 360 Global Conference.

fightehe.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Cholangiocarcinoma Foundation
TypeDirect peer
Description

Patient advocacy nonprofit for cholangiocarcinoma, a rare bile duct cancer. Runs research grants, patient registry, annual conference, and collaborates with biotech sponsors — directly comparable operating model in the rare-cancer patient advocacy space.

TypeBroad incumbent
Description

US umbrella organization for rare diseases hosting the EHE Foundation's registry on its IAMRARE platform. Provides infrastructure and advocacy across thousands of rare conditions — broader portfolio but overlapping patient-advocacy and registry capabilities.

TypeDirect peer
Description

Patient advocacy nonprofit for desmoid tumors, another ultra-rare sarcoma subtype. Comparable in mission (research funding, patient support, expert convening) and scale (small staff, ultra-rare patient population, research-grant-funded model).

4EHE Rare Cancer Charity (UK)
TypeDirect peer
Description

UK-based nonprofit dedicated to EHE with the same disease-specific mission. Co-funds the European EHE Research Collaboration with the Foundation and is a direct global counterpart serving the same patient population across geographies.

5National Leiomyosarcoma Foundation
TypeDirect peer
Description

Patient advocacy nonprofit focused on leiomyosarcoma, a rare soft-tissue sarcoma. Operates patient services, funds research, and hosts community events with a model closely paralleling the EHE Foundation's patient registry, support groups, and research grant programs.

6EHE Rare Cancer Foundation Australia
TypeDirect peer
Description

Australian nonprofit serving EHE patients, co-funding research grants including the Lamar Lab at Albany Medical College and Antonescu lab at Memorial Sloan Kettering alongside the Foundation. Sister organization addressing the same ultra-rare disease in a different geography.

TypeBroad incumbent
Description

Multi-institution consortium conducting sarcoma clinical trials including the SARC046 Phase 2 trial in EHE funded by the Department of Defense. Broader sarcoma scope but a key research partner with overlapping clinical-research mission.

8Rare Cancer EHE Deutschland e.V.
TypeDirect peer
Description

German EHE patient organization represented at EHE 360 Global Conference and contributing to the global EHE community. Direct disease peer serving German patients with the same patient-advocacy mission.

TypeDirect peer
Description

Patient advocacy nonprofit for GIST (gastrointestinal stromal tumor), another rare sarcoma. Operates a patient registry, funds research, and runs support programs with a comparable model to the EHE Foundation's biobank/registry/conference structure.

10EHE Italia
TypeDirect peer
Description

Italian EHE patient organization contributing to the global EHE community and participating in EHE 360 Global Conference leadership. Sister organization with same disease focus serving Italian patients and caregivers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The EHE Foundation

Rare Disease Patient Advocacyfightehe.org

The EHE Foundation is a 501(c)(3) nonprofit founded in 2015 that operates the EHE Global Patient Registry, EHE Biobank, and annual EHE 360 Global Conference to advance research and support patients with epithelioid hemangioendothelioma, an ultra-rare sarcoma affecting fewer than 1 in 1 million people worldwide.

What The EHE Foundation does

The EHE Foundation is a 501(c)(3) nonprofit organization founded in 2015 and headquartered in Hobart, Wisconsin (Green Bay area), dedicated to finding treatments and a cure for epithelioid hemangioendothelioma, an ultra-rare vascular sarcoma affecting fewer than 1 in 1 million people. It serves a global community of EHE patients, caregivers, researchers, and clinicians across at least 19 countries and five continents, and operates with a lean distributed team of 1-10 staff under Executive Director Denise Robinson.

The foundation's core offerings combine patient services with proprietary research infrastructure. Its technology stack centers on the EHE Global Patient Registry, hosted on the National Organization for Rare Disorders' IAMRARE platform, which collects standardized natural history data, and the EHE Biobank (established 2020), which distributes tissue and biospecimens to qualified researchers. Structured clinical data is enabled through a partnership with xCures. Patient-facing services include virtual support groups, a provider directory, clinical trial listings, the EHE Library of approximately 200 EHE-specific publications, and the monthly EHE 360 Connect webinar series, all provided free of charge. The annual EHE 360 Global Conference convenes the international community; the 2026 edition drew 187 registrants from 19 countries.

The foundation's business model is donation-driven rather than revenue-driven, consistent with its 501(c)(3) status. Funding is generated through individual donations processed via the Zeffy platform, the annual EHE Fun Run & Walk (per-registrant fees of $45 US / $65 international), corporate sponsorships (including Aadi Bioscience and SpringWorks Therapeutics), EHE Awareness Month campaigns, and grants. The foundation channels donor funds into a Research Grants Program that has committed over $2 million cumulatively to academic collaborators including Memorial Sloan Kettering, Cleveland Clinic, Albany Medical College, MIT Koch Institute, and Istituto Nazionale dei Tumori, and into operational infrastructure that supports a co-funded Department of Defense rare-cancer drug-target discovery platform and SARC's SARC046 Phase 2 clinical trial.

The EHE Foundation firmographics

Firmographics
Name
The EHE Foundation
Legal name
EHE Foundation
Website
https://fightehe.org
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
The EHE Foundation is a 501(c)(3) nonprofit founded in 2015 that operates the EHE Global Patient Registry, EHE Biobank, and annual EHE 360 Global Conference to advance research and support patients with epithelioid hemangioendothelioma, an ultra-rare sarcoma affecting fewer than 1 in 1 million people worldwide.
Ownership category
akta.pro rank

The EHE Foundation industry classification

Industry
Product category
Rare Disease Patient Advocacy
NAICS
Voluntary Health Organizations (813212), Grantmaking and Giving Services (8132)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Keywords

  • Rare disease research
  • Patient advocacy services
  • Sarcoma research funding
  • Patient registry operations
  • Tissue biobanking services

Where The EHE Foundation is headquartered

Location

Headquarters

HQ city
Hobart
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The EHE Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Donations and Fundraising: The EHE Foundation generates revenue primarily through individual donations, corporate sponsorships, and fundraising events including the annual EHE Fun Run & Walk and EHE Awareness Month campaigns. The foundation also receives grants from private donors and partner organizations.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

The EHE Foundation product offering

Product offering

Core offering

The EHE Foundation is a nonprofit patient advocacy organization that delivers free patient services (newly-diagnosed guidance, provider directory, support groups, educational resources), maintains research infrastructure including the EHE Global Patient Registry and EHE Biobank, funds EHE research grants, and convenes the global EHE community through the annual EHE 360 Global Conference, EHE 360 Connect webinars, and the EHE Fun Run & Walk fundraising event. All offerings are provided at no cost to patients and caregivers, funded through donations, sponsorships, and fundraising.

Product overview

The EHE Foundation offers a comprehensive suite of patient-focused services and research programs for Epithelioid Hemangioendothelioma (EHE), an ultra-rare vascular sarcoma. The core offerings include the EHE Global Patient Registry (hosted on NORD's IAMRARE platform) for patient-powered research data collection, the EHE Biobank for tissue and biospecimen donation, EHE Support Groups for peer support, EHE 360 Connect educational webinars, and the annual EHE 360 Global Conference. Additional resources include a Provider Directory, Clinical Trials Information, EHE Library of research publications, and the EHE Research Grants Program funding. Fundraising initiatives include the annual EHE Fun Run & Walk event.

Differentiator

Problem solved

Functional benefit

Products and services

  • EHE Global Patient Registry An online global patient-powered natural history study that collects standardized information about EHE patients' experiences over time to advance research and support clinical trial recruitment. Hosted by NORD on the IAMRARE platform. Available for free to EHE patients worldwide.
  • EHE Biobank An open, ongoing collection of tissue samples and biospecimens (blood, bodily fluids) donated by EHE patients. Samples are preserved and made available to qualified researchers to accelerate EHE research. Coordinated through the foundation's Biobank Coordinators.
  • EHE Support Groups Free virtual meetings for adults affected by EHE, professionally led covering topics that help support patients newly affected by EHE as well as those who have lived with EHE longer. Available to EHE patients and caregivers globally.
  • EHE 360 Connect Educational webinar program presenting information from clinicians and research communities on EHE topics. Recordings are archived and available for free viewing. Targets EHE patients, caregivers, researchers, and clinicians.
  • EHE 360 Global Conference Annual virtual international forum bringing together patients, caregivers, researchers, clinicians, and industry partners for substantive scientific and clinical education on EHE. The 2026 conference drew 187 registrants from 19 countries spanning five continents.
  • EHE Research Grants Program Research grants program funding innovative basic, translational, and clinical proposals to advance scientific knowledge in EHE. The foundation has committed over $2,000,000 to advance EHE research globally through this program. Targets academic researchers and clinicians.
  • EHE Fun Run & Walk Annual virtual community-driven awareness and fundraising event supporting people affected by EHE. Participants register and can join from anywhere globally to raise funds and awareness for the EHE community.
  • Provider Directory A searchable and sortable directory of clinicians with experience treating EHE, designed to help patients find sarcoma specialists familiar with the ultra-rare disease. Available free to EHE patients.
  • Clinical Trials Information A continuously updated list of active clinical trials that include patients diagnosed with EHE, with details and contacts accessible via ClinicalTrials.gov. Provided free to EHE patients seeking treatment options.
  • EHE Library A collection of nearly 200 publications and articles about EHE research and treatments available online, including both open access and subscription-required articles. Targets researchers, clinicians, and informed patients.

Quantifiable outcome

  • Over $2 million committed to EHE research globally
  • +2 more outcomes

Companies that use The EHE Foundation

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

The EHE Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

The EHE Foundation partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • National Organization for Rare Disorders (NORD)coreStrategic or Co-development PartnerNORD hosts the EHE Global Patient Registry on their IAMRARE platform, providing secure data collection infrastructure for natural history studies and clinical trial recruitment. NORD is a nonprofit leading the fight to improve lives of rare disease patients and families.
  • xCurescoreStrategic or Co-development PartnerPartnership with xCures, a pioneer in healthcare data management, to gather medical information from EHE patients into structured, regulatory-grade clinical data. The platform collects and organizes medical data to study the natural history of EHE.
  • CURE Drug Repurposing Collaboratory (CDRC)coreStrategic or Co-development PartnerEHE Foundation partners with CDRC, an initiative of the Critical Path Institute, as a member of the Sarcoma Task Force and Rare Coordinating Committee. CDRC explores whether existing drugs can be repurposed for ultra-rare sarcomas like EHE.
  • NCI MyPART NetworkcoreStrategic or Co-development PartnerPartnership with the MyPART network of NCI's Rare Tumors Initiative, focusing on accelerating translation of potential new therapies for rare tumors through a Natural History Study of Rare Solid Tumors.
  • EHE Rare Cancer Charity (UK)coreStrategic or Co-development PartnerUK-based EHE organization co-funding the European EHE Research Collaboration with the Istituto Nazionale dei Tumori in Milan, Institute of Cancer Research (UK), and Royal Marsden Hospital.
  • EHE Rare Cancer Foundation AustraliacoreStrategic or Co-development PartnerAustralian EHE organization co-funding research grants including the Lamar Lab at Albany Medical College and the Antonescu lab at Memorial Sloan Kettering.
  • SARCcoreStrategic or Co-development PartnerSARC (Sarcoma Alliance for Clinical Research) is conducting the SARC046 Phase 2 clinical trial of nab-sirolimus in EHE patients, funded by the US Department of Defense.
  • Cleveland Clinic (Lerner Research Institute)coreStrategic or Co-development PartnerResearch collaboration with Dr. Ajaybabu Pobbati's lab investigating FDA-approved drug repurposing for EHE treatment and CDK9 inhibitors for aggressive metastatic EHE.
  • Albany Medical College (Lamar Lab)coreStrategic or Co-development PartnerResearch collaboration with Dr. John Lamar's lab investigating statins as potential EHE treatment and development of blood-based biomarkers for disease monitoring.
  • Koch Institute for Integrative Cancer Research at MIT (Boehm Lab)coreStrategic or Co-development PartnerCollaboration with Dr. Jesse Boehm's lab, awarded a 3-year grant through the Department of Defense Rare Cancers Research Program, to create a platform for rare cancer drug target discovery using patient-donated tumor tissue.
  • Fondazione IRCCS Istituto Nazionale dei Tumori (Milan, Italy)coreStrategic or Co-development PartnerItalian research institution collaborating on European EHE Research Collaboration evaluating cytokines and hormones as biomarkers for EHE, funded jointly with EHE Rare Cancer Charity UK.
  • EHE ItaliaminorStrategic or Co-development PartnerItalian EHE patient organization contributing to the global EHE community and participating in EHE 360 Global Conference leadership.
  • Rare Cancer EHE Deutschland e.V. (Germany)minorStrategic or Co-development PartnerGerman EHE patient organization contributing to the global EHE community and represented at EHE 360 Global Conference.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

The EHE Foundation competitors and assessment

Company assessment

Direct peers

  • Cholangiocarcinoma Foundation: Patient advocacy nonprofit for cholangiocarcinoma, a rare bile duct cancer. Runs research grants, patient registry, annual conference, and collaborates with biotech sponsors — directly comparable operating model in the rare-cancer patient advocacy space.
  • Desmoid Tumor Research Foundation: Patient advocacy nonprofit for desmoid tumors, another ultra-rare sarcoma subtype. Comparable in mission (research funding, patient support, expert convening) and scale (small staff, ultra-rare patient population, research-grant-funded model).
  • EHE Rare Cancer Charity (UK): UK-based nonprofit dedicated to EHE with the same disease-specific mission. Co-funds the European EHE Research Collaboration with the Foundation and is a direct global counterpart serving the same patient population across geographies.
  • National Leiomyosarcoma Foundation: Patient advocacy nonprofit focused on leiomyosarcoma, a rare soft-tissue sarcoma. Operates patient services, funds research, and hosts community events with a model closely paralleling the EHE Foundation's patient registry, support groups, and research grant programs.
  • EHE Rare Cancer Foundation Australia: Australian nonprofit serving EHE patients, co-funding research grants including the Lamar Lab at Albany Medical College and Antonescu lab at Memorial Sloan Kettering alongside the Foundation. Sister organization addressing the same ultra-rare disease in a different geography.
  • Rare Cancer EHE Deutschland e.V. German EHE patient organization represented at EHE 360 Global Conference and contributing to the global EHE community. Direct disease peer serving German patients with the same patient-advocacy mission.
  • The Life Raft Group: Patient advocacy nonprofit for GIST (gastrointestinal stromal tumor), another rare sarcoma. Operates a patient registry, funds research, and runs support programs with a comparable model to the EHE Foundation's biobank/registry/conference structure.
  • EHE Italia: Italian EHE patient organization contributing to the global EHE community and participating in EHE 360 Global Conference leadership. Sister organization with same disease focus serving Italian patients and caregivers.

Broad incumbents

  • National Organization for Rare Disorders (NORD): US umbrella organization for rare diseases hosting the EHE Foundation's registry on its IAMRARE platform. Provides infrastructure and advocacy across thousands of rare conditions — broader portfolio but overlapping patient-advocacy and registry capabilities.
  • Sarcoma Alliance for Clinical Research (SARC): Multi-institution consortium conducting sarcoma clinical trials including the SARC046 Phase 2 trial in EHE funded by the Department of Defense. Broader sarcoma scope but a key research partner with overlapping clinical-research mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks2 records

Key highlights7 records

Customer concentration

The EHE Foundation social profiles

Digital presence

The EHE Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The EHE Foundation leadership team

Management profile

Number of profiles

Profiles7 records

The EHE Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The EHE Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The EHE Foundation

What does The EHE Foundation do?

The EHE Foundation is a nonprofit patient advocacy organization that delivers free patient services (newly-diagnosed guidance, provider directory, support groups, educational resources), maintains research infrastructure including the EHE Global Patient Registry and EHE Biobank, funds EHE research grants, and convenes the global EHE community through the annual EHE 360 Global Conference, EHE 360 Connect webinars, and the EHE Fun Run & Walk fundraising event. All offerings are provided at no cost to patients and caregivers, funded through donations, sponsorships, and fundraising.

Is The EHE Foundation a public or private company?

The EHE Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The EHE Foundation founded?

The EHE Foundation was founded in 2015. It employs 1 to 10 people.

Where is The EHE Foundation based?

The EHE Foundation is headquartered in Hobart, United States, in the North America region.

How does The EHE Foundation make money?

One revenue line is on record: donations and Fundraising.

Who are The EHE Foundation's main competitors?

Direct peers on record are Cholangiocarcinoma Foundation, Desmoid Tumor Research Foundation, EHE Rare Cancer Charity (UK), National Leiomyosarcoma Foundation, EHE Rare Cancer Foundation Australia, Rare Cancer EHE Deutschland e.V., The Life Raft Group and EHE Italia. Broad incumbents are National Organization for Rare Disorders (NORD) and Sarcoma Alliance for Clinical Research (SARC).

Does The EHE Foundation have an API?

No public API is recorded for The EHE Foundation.

What industry is The EHE Foundation in?

The EHE Foundation's product category is Rare Disease Patient Advocacy. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales